P98170 (XIAP_HUMAN) Homo sapiens (Human)
E3 ubiquitin-protein ligase XIAP UniProtKBInterProSTRINGInteractive Modelling
497 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
72 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| NMR STRUCTURE OF A 9 RESIDUE PEPTIDE FROM SMAC/DIABLO COMPLEXED TO THE BIR3 DOMAIN OF XIAP |
Heteromer Q9NR28; | 100 | 1×ZN; | |||
| CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3 |
Heteromer P42574; | 98.2 | 2×ZN; | |||
| STRUCTURE OF CASPASE-9 IN AN INHIBITORY COMPLEX WITH XIAP-BIR3 |
Heteromer P55211; | 100 | 1×ZN; | |||
| CRYSTAL STRUCTURE OF SMAC BOUND TO XIAP-BIR3 DOMAIN |
Heteromer Q9NR28; | 100 | ||||
| The Crystal Structure of TAB1 and BIR1 complex |
Heteromer Q15750; | 100 | 2×ZN; | |||
| Structure of RIP2K dimer bound to the XIAP BIR2 domain |
Heteromer O43353; | 100 | 1×ZN; | |||
| BIRC4 RING in complex with dimeric ubiquitin variant |
Heteromer P0CG47; | 100 | 4×ZN; 2×EDO; | |||
| CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP |
Heteromer P55210; | 100 | ||||
| CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX |
Heteromer P55210; | 100 | ||||
| Crystal Structure of the Caspase-7 / XIAP-BIR2 Complex |
Heteromer P55210; | 100 | ||||
| AVPF bound to BIR3-XIAP | homo-2-mer | 100 | 2×ZN; | |||
| XIAP-BIR3 in complex with a potent divalent Smac mimetic | homo-2-mer | 100 | 2×ZN; 1×0O6; 1×P33; | |||
| Fragment Derived XIAP inhibitor | homo-2-mer | 100 | 2×ZN; 2×FUK; | |||
| XIAP in complex with small molecule | homo-2-mer | 100 | 2×ZN; 1×NA; 2×A4E; | |||
| Smac mimic bound to BIR3-XIAP | homo-2-mer | 100 | 2×ZN; 2×CO9; | |||
| Crystal Structure of XIAP BIR3 domain in complex with a Smac-mimetic compound, Smac010 | homo-2-mer | 100 | 2×ZN; 2×X23; | |||
| Crystal Structure of XIAP-BIR3 domain in complex with Smac-mimetic compuond, Smac005 | homo-2-mer | 100 | 2×ZN; 4×X22; | |||
| Crystal structure of XIAP BIR3 domain in complex with a Smac-mimetic compound | homo-2-mer | 100 | 2×ZN; 2×SMK; | |||
| Crystal structure of XIAP BIR3 with T3256336 | homo-2-mer | 100 | 4×ZN; 2×1AQ; | |||
| Crystal structure of XIAP-BIR2 domain | homo-2-mer | 97.56 | 2×ZN; | |||
| Crystal structure of XIAP BIR1 domain (P21 form) | homo-2-mer | 100 | 2×ZN; 4×EOH; | |||
| Crystal structure of XIAP BIR1 domain (I222 form) | homo-2-mer | 100 | 2×ZN; | |||
| Structure of XIAP-BIR1 domain in complex with an NF023 analog | homo-2-mer | 100 | 2×ZN; 1×F2H; | |||
| Structure of XIAP-BIR1 in complex with NF023 | homo-2-mer | 100 | 2×ZN; 1×0BU; | |||
| Crystal structure of the RING domain of human XIAP | homo-2-mer | 100 | 4×ZN; 1×CA; | |||
| Crystal structure of the F495L mutant XIAP RING domain | homo-2-mer | 98.41 | 4×ZN; 2×NI; | |||
| Crystal structure of the XIAP RING domain | homo-2-mer | 100 | 4×ZN; 1×NI; | |||
| Crystal structure of the RING domain of human XIAP treated with arsenic trioxide | homo-2-mer | 100 | 4×ZN; 1×CA; | |||
| AVERAGE NMR SOLUTION STRUCTURE OF THE BIR-2 DOMAIN OF XIAP | monomer | 98.29 | 1×ZN; | |||
| AVERAGE NMR SOLUTION STRUCTURE OF THE BIR-3 DOMAIN OF XIAP | monomer | 100 | 1×ZN; | |||
| NMR Structure of an Antagonists of the XIAP-Caspase-9 Interaction Complexed to the BIR3 domain of X… | monomer | 100 | 1×ZN; 1×997; | |||
| NMR Structure of an Antagonists of the XIAP-Caspase-9 Interaction Complexed to the BIR3 domain of X… | monomer | 100 | 1×ZN; 1×998; | |||
| Fragment Derived XIAP inhibitor | monomer | 99.06 | 1×ZN; 1×NA; 1×FUE; | |||
| Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 4 | monomer | 100 | 1×ZN; 1×4XF; | |||
| Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 17 | monomer | 100 | 1×ZN; 1×4YF; | |||
| Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 18 | monomer | 100 | 1×ZN; 1×4YC; | |||
| Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 21 | monomer | 100 | 1×ZN; 1×4YN; | |||
| Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 20 | monomer | 100 | 1×ZN; 1×4YL; | |||
| Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 7 | monomer | 100 | 1×ZN; 1×4YE; | |||
| Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 2 | monomer | 100 | 1×ZN; 1×4WJ; | |||
| Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 1 | monomer | 100 | 1×ZN; 1×4XE; | |||
| Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 5 | monomer | 100 | 1×ZN; 1×4YD; | |||
| Small Molecule inhibitors of IAP | monomer | 100 | 1×ZN; 1×NA; 1×DMS; 1×7HT; | |||
| Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 3 | monomer | 100 | 1×ZN; 2×EDO; 1×4WK; | |||
| Small Molecule inhibitors of IAP | monomer | 100 | 1×ZN; 1×NA; 1×7HU; | |||
| Small Molecule inhibitors of IAP | monomer | 100 | 1×ZN; 1×NA; 1×7H9; | |||
| Small Molecule inhibitors of IAP | monomer | 100 | 1×ZN; 1×NA; 1×7H8; | |||
| Small Molecule inhibitors of IAP | monomer | 100 | 1×ZN; 1×NA; 1×7J6; | |||
| Crystal structure of XIAP BIR3 domain in complex with a Smac-mimetic compound, Smac005 | monomer | 100 | 1×ZN; 1×X22; | |||
| Crystal structure of XIAP-BIR3 in complex with a cIAP1-selective SM | monomer | 100 | 1×ZN; 1×C3T; | |||
| XIAP BIR3 bound to a Smac Mimetic | monomer | 100 | 1×BI6; 1×ZN; | |||
| Crystal structure of XIAP-BIR3 in complex with a bivalent compound | monomer | 100 | 1×ZN; 1×CZ3; | |||
| Crystal Structure of XIAP BIR3 with a Bivalent Smac Mimetic | monomer | 100 | 1×15P; 1×ZN; | |||
| 142D6 bound to BIR3-XIAP | monomer | 100 | 1×ZN; 1×7PE; | |||
| Structure of XIAP-BIR3 and inhibitor | monomer | 100 | 1×ZN; | |||
| Solution structure of UBA domain of XIAP | monomer | 100 | ||||
| Crystal structure of XIAP BIR3 with CS3 | monomer | 100 | 1×ZN; 1×9JZ; | |||
| Crystal structure of XIAP-BIR2 domain with AMRV bound | monomer | 97.59 | 1×ZN; 1×SO4; | |||
| Crystal structure of XIAP-BIR2 domain with AIAV bound | monomer | 97.56 | 1×ZN; | |||
| Crystal structure of XIAP-BIR2 domain with SVPI bound | monomer | 97.56 | 1×ZN; | |||
| Crystal structure of XIAP-BIR2 domain with AVPI bound | monomer | 97.56 | 1×ZN; | |||
| Crystal structure of XIAP-BIR2 domain with ATAA bound | monomer | 97.56 | 1×ZN; | |||
| Crystal structure of XIAP-Bir2 with a bound spirocyclic benzoxazepinone inhibitor. | monomer | 97.56 | 1×ZN; 1×1RK; | |||
| Crystal structure of XIAP-Bir2 with a bound benzodiazepinone inhibitor. | monomer | 97.53 | 1×ZN; 1×1RH; | |||
| Structure of XIAP-BIR1 V86E mutant | monomer | 98.72 | 1×ZN; 1×NA; | |||
| Crystal structure of XIAP BIR1 domain | monomer | 100 | 1×ZN; | |||
| Crystal structure of XIAP-BIR2 domain complexed with ligand bound | monomer | 97.37 | 1×ZN; | |||
| CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN COMPLEXED WITH LIGAND BOUND | monomer | 97.37 | 1×ZN; 1×SO4; 1×GOL; | |||
| Crystal structure of XIAP-BIR2 domain complexed with (S)-3-(4-methoxyphenyl)-2-((S)-2-((S)-1-((S)-2… | monomer | 97.37 | 1×ZN; 3×SO4; 1×GOL; | |||
| Solution structure of the ring domain of the Baculoviral IAP repeat-containing protein 4 from Homo … | monomer | 100 | 2×ZN; | |||
| Crystal structure of cIAP1 BIR3 bound to GDC0152 | monomer | 100 | 2×ZN; | |||
| Crystal structure of the BIR domain of MLIAP bound to GDC0152 | monomer | 100 | 1×ZN; 1×SO4; | |||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2kna.1.A | monomer | 0.74 | 100.00 | |||
| 3t6p.1.A | monomer | 0.71 | 1×ZN; | 42.04 | ||
| 8w5a.1.B | monomer | 0.64 | 2×ZN; | 100.00 | ||